ArchiMed

ArchiMed SAS is a private equity firm established in 2014 and headquartered in Lyon, France, with an additional office in New York. The firm specializes in investing in small to mid-cap companies within the healthcare sector, focusing on areas such as care and wellness, medtech, biopharma, and public health. ArchiMed targets investments typically ranging from €5 million to €15 million, with the flexibility to invest between €2 million and €50 million or more, either alone or alongside co-investors. The firm seeks companies with revenues between €5 million and €100 million, though it can consider larger entities as well. ArchiMed primarily focuses on Western Europe, particularly France, the United Kingdom, and Switzerland, and it takes both minority and majority stakes, primarily in unlisted companies. The firm's funding sources include contributions from its team and investments from European and American institutional and private investors, including experienced healthcare entrepreneurs.

Ludovic Alonzi

Senior Associate

Robin Filmer-Wilson

Managing Partner

Vincent Guillaumot

Founder and Managing Partner

Loïc Kubitza

Operating Partner

Sandrine Laporte

Chief Financial Officer

Stefano Munnia

Private Equity Analyst

Luca Di Santo

Associate Director

Clotilde Schnepp

Senior Analyst

Benoît Varichon

Director

Theodor Wuppermann

Senior Associate

22 past transactions

Corealis Pharma

Venture Round in 2022
Corealis Pharma provides services on a contract basis in the areas of formulation and process development as well as in small-scale clinical trial material manufacturing and the packaging of solid dosage forms to pharmaceutical and biotech companies. Its services include API characterization, salt selection, pre-formulation, formulation and process development, analytical method development, stability storage, and testing, technical transfer and scale-up, cGMP manufacturing and packaging of phase I and II CTM, and dossier support.

Xpress Biologics

Acquisition in 2021
Xpress Biologics is a company providing a large range of services from the design of expression systems to pre-clinical productions. As a One-Stop-Shop, Xpress Biologics can also ensure the management of clinical trials.

Suanfarma

Acquisition in 2021
Suanfarma is a company specializing in the development, manufacture, and distribution of raw materials and finished dosage forms for the pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. It provides a diverse range of generics and active pharmaceutical ingredients, including those for anti-infective, cardiovascular, central nervous system, digestive, endocrine, oncology, respiratory, and pain management applications. Additionally, Suanfarma offers food supplements and medicinal plants, alongside active ingredients for the veterinary industry, such as antibiotics and antiparasitics. The company also focuses on developing alternative synthesis routes for active pharmaceutical ingredients and supports biotechnology firms with business management and regulatory guidance. Founded in 1993 and headquartered in Alcobendas, Spain, Suanfarma serves both national and international customers, with locations across several countries in North America, Latin America, Europe, the Middle East, and Asia.

Stragen

Acquisition in 2021
Stragen is an international, privately held healthcare company focused on the development, registration and worldwide distribution of:- pharmaceutical specialties for Women’s Health, Hospital Supplies and Biosimilars- consumer health products- new patented molecules from laboratory to proof of concept Stragen offers a large portfolio specialising in cardiology, infectiology, neurology, hematology and women’s health.

NAMSA

Acquisition in 2020
NAMSA is a medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. At every stage of the product development process, they provide strategic guidance and tactical support to help clients commercialize medical products in the major markets of the world. They serve as your trusted partner, using their insight to identify strategies for saving time, while never compromising quality. They know that compromised quality can quickly take your product right back to the starting line. That’s why it’s so important to have a smart strategy from the outset—and why they put it at the forefront of every project.

ActiGraph

Acquisition in 2020
ActiGraph, LLC develops wearable ambulatory monitoring technology. It also develops software, data analytics, and management solutions. It offers activity monitors, centrepoint insight watch, actigraph GT9X link, wGT3X-BT, activity monitor comparsion; centrepoint, centrePoint platform, centrepoint data hub; actilife; and accessories. The company was incorporated in 2004 and is based in Pensacola, Florida.

Direct Healthcare Group

Acquisition in 2019
Direct Healthcare Group Ltd. is a British company that specializes in designing, manufacturing, and supplying healthcare accessories and pressure area solutions. The company provides a diverse range of products, including hybrid, static, and dynamic mattresses, cushions, and beds tailored for bariatric, residential, and homecare use. Its offerings also encompass wheelchairs, air cushions, recliners, and scale systems, marketed under the brands DYNA-FORM, KIRTON, and NIGHTINGALE. In addition to product manufacturing, Direct Healthcare Group offers various services, such as equipment auditing, collection and decontamination, infection control, and equipment rental and leasing. The company serves sectors including community health, nursing homes, and wheelchair services both in the United Kingdom and internationally. Established in 2004 and based in Caerphilly, the company also operates an office in Webley, Australia. In November 2017, it rebranded from Direct Healthcare Services Ltd. to its current name.

EuroLyser

Acquisition in 2019
EuroLyser develops point-of-care testing devices and kits. We are convinced that medical diagnostics are a key element of modern day healthcare. The faster and more precise a doctor can determine what the patient needs, the faster they can commence treatment.

Diesse

Acquisition in 2019
Diesse is an Italian developer of innovative in vitro diagnostic (‘IVD’) systems for the diagnosis of infectious and autoimmune diseases.

Bomi Group

Acquisition in 2019
Bomi Italia S.p.A. provides logistics and management services for products related to health protection. The company offers warehousing, transportation, return management, reverse logistics, and consignment stock management services, as well as satellite stock solutions. It also provides orthopedic kits management services, including collection, decontamination, control, and delivery services. The company distributes medical products and devices to professional institutions, including hospitals, clinics, and laboratories, as well as to patients’ homes. It operates in 20 countries worldwide. The company was founded in 1985 and is headquartered in Vaprio d’Adda, Italy.

Clean Cells

Venture Round in 2018
Clean Cells SAS, founded in 2000 and based in Boufféré, France, specializes in quality control, training, and product development services for the biopharmaceutical industry. The company provides essential services such as viral and biological safety testing, as well as the production and secure storage of GMP-grade cell and virus banks. Additionally, Clean Cells engages in biobanking for research, clinical applications, and biomanufacturing, ensuring compliance with international regulatory standards. Their offerings include in vivo, in vitro, and custom-made tests to guarantee the safety of biological products throughout the production process. Clean Cells is also involved in the production of experimental therapies, including cell therapy products and therapeutic phages, positioning itself as a key player in the advancement of personalized medicine.

Provepharm life Solutions

Acquisition in 2018
Provepharm life Solutions is a truly unique life sciences research and pharma company, dedicated to a new era of discovery. We are a new global leader in human health with new Life Solutions, manufactured and developed from our core technology: Molecule Vitalization. As PROVEPHARM LIFE SOLUTIONS, we are building a new powerhouse for Research Services, Manufacturing Services and Speciality Care.

Soest Medical Group

Acquisition in 2018
Soest Medical Group is a Netherlands-based company founded in 1990, specializing in the development and production of self-adhesive medical supplies designed to secure protective drapes to patients' skin during surgical procedures. The organization focuses on creating both reusable and disposable products to meet the diverse needs of hospitals and medical care institutions. By collaborating closely with universities and hospitals, Soest Medical Group emphasizes innovation and continuous improvement of its product offerings. Their commitment to connecting with customers and the medical industry underlines their mission to enhance patient care through effective solutions in surgical environments.

Fytexia

Acquisition in 2016
Fytexia SAS, based in Vendres, France, specializes in producing natural ingredients for the dietary supplement and health food industry, both domestically and internationally. Established in 2003, the company offers a range of innovative and scientifically validated ingredients that promote various health benefits. Its product lineup includes Sinetrol for weight loss, Mediterranean polyphenol concentrates, and Fiit-ns, a solution aimed at metabolic anti-aging. Additionally, Fytexia provides MANGOSELECT for joint health, OLEACTIV for cardiovascular support, and several products tailored for athletes, such as PerfLoad for explosive power, BurntoRun for endurance, and TensLess for recovery. The company focuses on leveraging the health benefits associated with the Mediterranean diet to support clients in addressing health challenges and enhancing overall well-being.

Polyplus-transfection

Acquisition in 2016
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.

Micromed Group

Acquisition in 2016
Micromed S.p.A. is an Italian company specializing in the design, development, and manufacturing of electro medical devices for neurophysiology diagnostics. Established in 1982 and headquartered in Venice, Italy, the company produces a range of products including EEG and sleep systems, EMG/EP systems, electrical stimulators, and related software and accessories. Micromed's devices are utilized in various medical applications such as digital EEG, holter poligraphy, evoked potential testing, electromyography, and polysomnography. The company serves a diverse clientele, including laboratories dedicated to neurophysiology, neurology, child neurology, epilepsy, and sleep centers, as well as rehabilitation and intensive care units. With a commitment to innovation, Micromed operates on an international scale, providing advanced diagnostic solutions in the field of neurophysiology.

Herb's International Service

Acquisition in 2016
Herb's International Service is a French leader in natural health ingredients. A team of 25 people who are passionate with botanicals. An agile company expert in sourcing herbal raw material. Sourcing means genuine quality, traceability, environment and ethical practices. We are audited each year by Ecocert and we have been granted the excellence label as a responsible company. We believe in partnership and work closely with our farmers, contract manufacturers to deliver the best ingredients to our customers. We design many type of natural ingredients using our raw material and we share our expertise with you. Service is key for us. We are dedicated to your projects.

RehabWorks Ltd.

Acquisition in 2015
RehabWorks Ltd., founded in 1987 and based in Bury St. Edmunds, United Kingdom, specializes in injury management and rehabilitation services for various sectors, including industry and insurance. The company offers a range of services focused on both preventative measures and treatment for physical and mental health conditions, particularly musculoskeletal and psychological issues that are common causes of workplace absence. By employing a biopsychosocial approach and comprehensive case management, RehabWorks aims to facilitate the recovery process while involving the workplace as a critical component. Their services include physiotherapy, psychological therapy, and workplace wellness programs designed to reduce absence rates and provide significant financial savings for employers. The company has established a strong reputation for delivering effective occupational health solutions and has been recognized for its award-winning psychological therapy services since 2009.

Deallus

Acquisition in 2015
Deallus Consulting Ltd. operates as a life science consulting company. The company offers consulting advice in the areas of product strategy, corporate strategy, research and development, business development, manufacturing and supply strategy, and competitive analysis. It serves customers worldwide. The company was founded in 2004 and is based in London, United Kingdom. It has regional offices in Europe, North America, and the Asia Pacific.

Centri Dentistici Primo

Venture Round in 2015
Trust is the basis of every relationship. First knows. Our method of care is based on absolute seriousness and transparency to reach a clear and sincere relationship with the patient.

Centri Dentistici Primo

Private Equity Round in 2015
Trust is the basis of every relationship. First knows. Our method of care is based on absolute seriousness and transparency to reach a clear and sincere relationship with the patient.

citieffe s.r.l.

Venture Round in 2014
Citieffe s.r.l. develops, manufactures and sells innovative and patented products such as intramedullary nails for trochanter fractures or sophisticated reconstruction-focused external fixation devices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.